(Q43559620)

English

Prediction of survival by neutropenia according to delivery schedule of oxaliplatin-5-Fluorouracil-leucovorin for metastatic colorectal cancer in a randomized international trial (EORTC 05963).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Prediction of survival by neutropenia according to delivery schedule of oxaliplatin-5-Fluorouracil-leucovorin for metastatic colorectal cancer in a randomized international trial (EORTC 05963). (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

metastatic colon cancer

1 reference

based on heuristic

inferred from title

Georg A. Bjarnason

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Marco Tampellini

object named as

Marco Tampellini

9

0 references

4

object named as

Rune Smaaland

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

author name string

Pasquale F Innominato

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sylvie Giacchetti

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Thierry Moreau

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Christian Focan

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Carlo Garufi

7

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Stefano Iacobelli

8

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Salvatore Tumolo

10

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Carlos Carvalho

11

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Abdoulaye Karaboué

12

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Francis Lévi

13

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

ARTBC International Chronotherapy Group

14

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

language of work or name

0 references

publication date

1 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Chronobiology International

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

586-600

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Rhythms in human gastrointestinal mucosa and skin.

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Circadian variation in the expression of cell-cycle proteins in human oral epithelium

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Differences in toxicity between men and women treated with 5-fluorouracil therapy for colorectal carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

The mammalian circadian timing system: organization and coordination of central and peripheral clocks

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Dosing strategies for anticancer drugs: the good, the bad and body-surface area

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Host circadian clock as a control point in tumor progression.

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Effects of chronic jet lag on tumor progression in mice.

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Individual fluorouracil dose adjustment based on pharmacokinetic follow-up compared with conventional dosage: results of a multicenter randomized trial of patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Chronotherapy of colorectal cancer

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Tumor-based rhythms of anticancer efficacy in experimental models.

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Circadian optimisation of irinotecan and oxaliplatin efficacy in mice with Glasgow osteosarcoma.

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Circadian cancer therapy

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Chronotherapy and the molecular clock: Clinical implications in oncology.

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

The leucocyte nadir, a predictor of chemotherapy efficacy?

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

From circadian rhythms to cancer chronotherapeutics

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Circadian rhythms: mechanisms and therapeutic implications

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Cross-talks between circadian timing system and cell division cycle determine cancer biology and therapeutics

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Implications of circadian clocks for the rhythmic delivery of cancer therapeutics

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Circadian timing in cancer treatments.

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Mammalian circadian signaling networks and therapeutic targets.

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7).

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

The role of clock genes in pharmacology

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Ethics and methods for biological rhythm research on animals and human beings

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Metabolism and cancer: the circadian clock connection

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study Group

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Neutropaenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX.

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Meta-analysis of neutropenia or leukopenia as a prognostic factor in patients with malignant disease undergoing chemotherapy

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Neutropenia as a prognostic factor in advanced gastric cancer patients undergoing second-line chemotherapy with weekly paclitaxel

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

DNA cell cycle distribution and glutathione (GSH) content according to circadian stage in bone marrow of cancer patients

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Rhythms in human bone marrow and blood cells

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

The genetics of mammalian circadian order and disorder: implications for physiology and disease

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Predictive value of chemotherapy-induced neutropenia for the efficacy of oral fluoropyrimidine S-1 in advanced gastric carcinoma.

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Dissecting variability in responses to cancer chemotherapy through systems pharmacology

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Is chemotherapy-induced neutropenia a prognostic factor in patients with ovarian cancer?

1 reference

https://api.crossref.org/works/10.3109%2F07420528.2011.597532

21 January 2018

Identifiers

10.3109/07420528.2011.597532

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43559620&oldid=2100783146"